BioCentury | Dec 30, 2016
Company News

Transgene, ElsaLys deal

...worldwide rights, except in greater China, to develop and commercialize preclinical immuno-oncology candidate ELB041 (formerly TG3003...
...Shanghai:600535, Tianjin, China) share a JV to develop biotechnology products for the Chinese market, including ELB041...
...6, 2012 ). Transgene S.A. (Euronext:TNG), Illkirch, France ElsaLys Biotech , Lyon, France Business: Cancer Alex Himes TG3003 ElsaLys...
BioCentury | Aug 6, 2012
Company News

Transgene, Tasly Pharmaceutical deal

...commercialize products in China and Taiwan. The JV will initially develop four products from Trangene: TG3003...
Items per page:
1 - 2 of 2